Location History:
- Kobe, JP (1989)
- Tsukuba, JP (2005 - 2007)
- Ibaraki, JP (2006 - 2007)
Company Filing History:
4 out of 1,858 
1 out of 1,185 
Years Active: 1989-2007
Title: Nozomi Katayama: Innovator in Protein and DNA Research
Introduction
Nozomi Katayama is a prominent inventor based in Tsukuba, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of proteins and DNA that have therapeutic applications. With a total of 5 patents, her work focuses on addressing critical health issues such as diabetes and hyperglycemia.
Latest Patents
Katayama's latest patents include groundbreaking inventions related to gene and protein use. One of her notable patents describes a protein and DNA encoding that serves as a preventive or remedy for diseases like hypoglycemia. This protein is also useful as a reagent for screening compounds that inhibit its binding to insulin-responsive aminopeptidase (IRAP) or glucose transporter 4 (GLUT4). Such compounds can be vital in preventing or treating conditions like hyperglycemia and diabetes mellitus. Another patent highlights proteins with Na/glucose transporter activity, along with methods for screening compounds that enhance or inhibit this activity. These proteins can serve as diagnostic markers for diabetes and can be used as therapeutic agents for related diseases.
Career Highlights
Throughout her career, Nozomi Katayama has worked with esteemed organizations such as Takeda Chemical Industries, Inc. and Takeda Pharmaceutical Company Limited. Her experience in these companies has allowed her to collaborate on innovative projects that push the boundaries of medical science.
Collaborations
Katayama has collaborated with notable colleagues, including Hideaki Tojo and Shigeya Kakimoto. These partnerships have contributed to her success in the field and have fostered an environment of innovation and discovery.
Conclusion
Nozomi Katayama's contributions to protein and DNA research have the potential to significantly impact the treatment of diabetes and related diseases. Her innovative patents and collaborations highlight her role as a leading inventor in biotechnology.